Entrada Therapeutics
TRDA
TRDA
115 hedge funds and large institutions have $179M invested in Entrada Therapeutics in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
3.09% less ownership
Funds ownership: 82.53% → 79.44% (-3.1%)
15% less capital invested
Capital invested by funds: $210M → $179M (-$31.7M)
Holders
115
Holding in Top 10
4
Calls
$111K
Puts
$81K
Top Buyers
| 1 | +$3.91M | |
| 2 | +$3.86M | |
| 3 | +$1.46M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.37M |
| 5 |
Renaissance Technologies
New York
|
+$1.25M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$10.2M | |
| 3 | -$2.69M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$685K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$617K |
